Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 3, 2009, Pages 323-335

  Schulte, Paul A ^a   Schubauer Berigan, Mary K ^a   Mayweather, Candis ^b   Geraci, Charles L ^a   Zumwalde, Ralph ^a   McKernan, John L ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; NANOPARTICLE;

AIR POLLUTION; HEALTH CARE UTILIZATION; HEALTH HAZARD; HEALTH SURVEY; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SOCIETY; NANOANALYSIS; NANOTECHNOLOGY; REVIEW;

ANIMALIA;

EID: 63449140084     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181990c2c     Document Type: Article

References (103)

1. Australian Safety and Compensation Council. A Review of the Potential Occupational Safety and Health Implications of Nanotechnvlogy. Australian Safety and Compensation Council; 2006. Available at; http://www.ascc.gov.au/ ascc/HealthSafety/ Emerginglssues/Nanotechnology.
2. British Standards Institute. Guide to Safe Handling and Disposal of Manufactured Nanomaterials. British Standards Institute; 2007. Available at: http://www.bsi-global.com/en/Standards-and-Publications/ Industry-Sectors/ Natiotechnologies/ PD-6699-2/Download-PD6699-2-2007/.
3. Health and Safety Executive. Nanotech- nology HSE Information Note. Horizon Scanning Note No. HSINI. London: Health and Safety Executive; 2004:4.
4. Institut de Recherche Robert-Sauve' en Sante' du Travail. Nanoparticles: Actual Knowledge About Occupational Health and Safety Risks and Prevention Measures. Studies and Research Projects R-470. Montreal, Canada: IRSST; 2006: 100. Available at: http://www.irsst.qc.ca/ files/documents/PubIRSST/R-470.pdf.
5. National Institute for Occupational Safety and Health. Approaches to Safe Nanotechnology: an Information Exchange With NIOSH. Cincinnati, Ohio: NIOSH; 2006:43. Available at: http://www.cdc.gov/niosh/topics/nanotech/ safenano/.
6. Borm PJA, Robbins D, Haubold S, et al. The potential risks of nanoparticles: a review carried out for ECETOC. Pan Fibre Toxicol. 2006:3:11.
7. Oberdflrster G, Oberdorster E, Oberdor- ster J. Nanotoxicology-an emerging discipline involving studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839.
8. Shvedova AA, Kisin ER, Murray AR, et al. Inhalation versus aspiration of single walled carbon nanotubes in C5b1/6 mice: inflammation, fibrosis, oxidative stress and mutagenesis. Am J Physiol Lung Cell Mol Physiol. 2008 ;295: L552-L565.
9. Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibro- genic pulmonary responses to single- walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol. 2005; 289:L698-L708.
10. Zhang Q, Kusaka Y, Donaldson K. Comparative pulmonary responses caused by exposure to standard cobalt and ultrafine cobalt. J Occup Health. 2000;42:179-184.
11. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, Kluz T. et al. Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health. 2003;45:23-30.
12. Holman MN, Novotny M, Kemsley M, et al. The Nanotech Report. 5th ed. New York: Lux Research; 2007:1-298.
13. National Nanotechnology Coordination Office. Strategy for Nanotechnology- Related Environmental, Health, and Safety Research. Washington, DC: NNCO; 2008:33.
14. National Institute for Occupational Safety and Health. Criteria for a Recommended Standard: Occupational Exposure to Radon Progeny in Underground Mines. Cincinnati, OH: DHHS, Centers for Disease Control and Prevention (NIOSH), Publication No. 88-101; 1987.
15. Park RM, Rice F, Stayner L, Smith RJ, Gilbert S, Checkoway H. Exposure to crystalline silica, silicosis and lung disease other than cancer in diatomaceous earth industry workers: a quantitative risk assessment. Occup Environ Med. 2002;59:36-43.
16. Park RM, Bena JF, Stayner LT, Smith RJ, Gibb HJ, Lees PSJ. Hexavalent chromium and lung cancer in the chro - mate industry: a quantitative risk assessment. Risk Analysis. 2004;24: 1099-1108.
17. Oberdörster G, Stone V, Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology. 2007;1:2-25.
18. Boccuni F, Rondinone B, Petyx C, Ia- vicoli S. Potential occupational exposure to manufactured nanoparticles in Italy. J Clean Prod. 2008;16:949-956.
19. Tran CL, Donaldson K, Stone V, et al. A Scoping Study to Identify Hazard Data Needs for Addressing the Risks Presented by Nanoparticles and Nano- tubes. Research Report. Edinburgh, UK: Institute of Occupational Medicine; 2005.
20. Maynard AD, Aitken RJ. Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology. 2007;1:26-41.
21. Helland A, Wick P, Koehler A, Schmid K, Som C. Reviewing the environmental and human health knowledge base of carbon nanotubes. Environ Health Per- spect. 2007;115:1125-1131.
22. 2 in the rat. Int J Hyg Environ Health. 2002;205:239-244.
23. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki Y, Ohata T. Physiochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett. 2004;4:2163-2169.
24. Oberdörster G, Maynard A, Donaldson K, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:35.
25. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007;97:163-180.
26. Tran CL, Hankin SM, Ross B, et al. An Outline Scoping Study to Determine Whether High Aspect Ratio Nanoparticles (HARN) Should Raise the Same Concerns as Do Asbestos Fibres. Report on Project CB0406. Edinburgh, UK: Institute of Medicine; 2008.
27. Mark D. Occupational Exposures to Nanoparticles and Nanotubes. Issues in Environmental Science and Technology No 24: Nanotechnology: Consequence for Human Health and the Environment. Cambridge, UK: The Royal Society of Chemistry; 2007:50-80. Available at: http://www.rsc.org/images/Occupational% 20Exposure%20to%20Nanoparticles% 20and%20Nanotubes-tcml8-l 14957.pdf.
28. Gwinn MR, Vallyathan V. Nanoparticles: health effects-pro and cons. Environ Health Perspect. 2006; 114: 1818-1825.
29. American National Standards Institute. NSP 022-2004 Group III: Carbon Nanostructures. American National Standards Institute; 2004. Available at: http://publicaa. ansi.org/sites/apdl/ Documents/Standards%20Activities/ ANSI-NSP/ANSI-NSP%20022-2004% 20group%203.pdf.
30. Dunens OM, Mackenzie KJ, See CH, Harris AT. Inconsistencies in the carbon nanotube patent space: a scientific perspective. Nanotechnol Law Bus. 2008; 5:25-40.
31. ISO/TS 27687. Nanotechnologies-Terminology and Definitions for Nano- objects, Nanoparticle, Nanofibre, Nameplate. ISO/TS; 2008.
32. Davies JC. EPA and Nanotechnology: Oversight for the 21st Century. Program on Emerging Nanotechnologies. Washington, D.C.: Woodrow Wilson International Center for Scholars; 2007. Available at: http://www. nanotechprqject. org/process/assets/files/2698/197- nanoepa-pen9.pdf.
33. John Oliver; BBC Research. Carbon Nanotubes: Technologies and Commercial Prospects. Research Report No. GB-NAN024C. BBC Research; 2007: 291. Available at: www.electronics.ca/ reports/nanotechnology/nanotubes- technologies.html.
34. Aitken RJ, Creely KS, Tran CL. Nanoparticles: an Occupational Hygiene Review. Research Report 274. Norwich, UK: HSE Books; 2004.
35. Donaldson K, Tran L, Jimenez LA, et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol. 2005;2:10-14.
36. Pietropaoli AP, Frampton MW. Ober- dorster G, et al. Blood markers of coagulation and inflammation in healthy subjects exposed to carbon ultrafine particles. In: Heinrich U, ed. Effects of Air Contaminant on the Respiratory Tract-Interpretations from Molecular to Meta Analysis. Stuttgart, Germany: INIS Monographs, Fraunhofer IRB Verlag; 2004:181-194.
37. Maynard AD, Kuempel ED. Airborne nanostructural particles and occupational health. J Nanopart Res. 2005;7: 587-614.
38. Oberdörster G, Yu CP. The carcinogenic potential of inhaled diesel exhaust: a particle effect? J Aerosol Sci. 1990;21:S397-S401.
39. Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K. Lung cancer, cardiopulmonary mortality and long term exposure to fine paniculate air pollution. JAMA. 2002;287:1132-1141.
40. Pope CA, Burnett RT, Thurston GD,et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71-74.
41. Tetley TD. Health effects of nanomaterials. Biochem Soc Trans. 2007;35: 527-531.
42. Ibald-Mulli A, Wichmann HE, Kreyl- ing W, et al. Epidemiological evidence on health effects of ultrafine particles. J Aerosol Med Depos. 2002; 15:189-201.
43. Ambroise D, Wild P, Moulin JJ. Update of a meta-analysis on lung cancer and welding. Scand J Work Environ Health. 2006;32:22-31.
44. Antonini JM, Stone S, Roberts JR, et al. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol Appl Pharmacol. 2007;223:234-245.
45. Castranova V. From coal mine dust to quartz: mechanisms of pulmonary pathogenicity. Inhal Toxicol. 2000; (Suppl. 3):7-14.
46. Chalupa DC, Morrow PE, Oberdörster G, Utell MJ, Frampton MW. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect. 2004; 112:879-882.
47. Dockery DW, Pope CA, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329:1753-1759.
48. Garshick E, Laden F, Hart JE, et al. Lung cancer in railroad workers exposed to diesel exhaust. Environ Health Perspect. 2004;112:1539-1543.
49. Stayner L, Dankovic D, Smith R, et al. Predicted lung cancer risk among miners exposed to diesel exhaust particles. Am J Ind Med. 1998;34:207-219.
50. Sydbom A, Blomberg A, Parma S, Slen- fors N, Sandstrom T, Dahlen SE. Health effects of diesel exhaust emissions. Eur RespirJ. 2001;17:733-746.
51. Tornqvist H, Mills NL, Gonzalez M, et al. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med. 2007; 176: 395-400.
52. Wichmann H-E, Spix C, Tuch T, et al. Daily mortality and fine and ultrafine particles in Erfurt, Germany part 1: role of particle number and particle mass. Res Rep Health Efflnst. 2000;98:5-86.
53. Merget R, Bauer T, Kupper HU, et al. Health hazards due to the inhalation of amorphous silica. Arch Toxicol. 2002; 75:625-634.
54. Wellmann J, Weiland SK, Neiteler G, Klein G, Straif K. Cancer mortality in German carbon black workers 1976-98. Occup Environ Med. 2006;63:513-521.
55. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol. 2006;36:189-217.
56. Li Z, Hulderman T, Salmen R, et al. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect. 2007; 115: 377-382.
57. Mercer RR, Scabilloni J, Wang L, et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol. 2008;294:L87-L97.
58. Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008:423-428.
59. Takagi A, Hirose A, Nishimara T, et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105-116.
60. Elder A, Gelein R, Silva V, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006; 114:1172-1178.
61. Kreyling WG, Semmler M, Erbe F, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size depen-dent but very low. J Toxicol Environ Health A. 2002;65:1513-1530.
62. Nemmar A, Hoet PHM, Vanquicken- borne B, et al. Passage of inhaled particles into die blood circulation in humans. Circulation. 2002;105:411-414.
63. Shvedova AA, Fabisiak JP, Kisin ER, et al. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am J Respir Cell Mol Biol. 2008:38:579- 590.
64. Kuempel ED, Geraci CL, Schulte PA. Risk assessment and research needs for nanomaterials: an examination of data and information from current studies. In: Simeonova PP, et al. eds. Nanotechnology-Toxicological Issues and Environmental Safety: Proceedings of the NATO Advanced Research Workshop on Nanotechnology-Toxicological Issues and Environmental Safety, Varna, Bulgaria, 12-17 August, 2006. New York: Springer; 119-145.
65. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77:126-134.
66. Mauderly JL. Relevance of particle- induced rat lung tumors for assessing lung carcinogenic hazard and human lung cancer risk. Environ Health Perspect. 1997;105:1337-1346.
67. Hoet PM, Bruske-Hohlfeld I, Salata OV. Nanoparticles-known and unknown health risks. J Nanohiotechnol. 2004;2:12.
68. National Institute for Occupational Safety and Health. Interim Guidance for Medical Screening and Hazard Surveillance for Workers Potentially Exposed to Engineered Nanoparticles. Cincinnati. OH: DHHS, Centers for Disease Control and Prevention (NIOSH); 2009.
69. Evans DE, Heitbrink WA, Slavin TJ, Peters TM. Ultrafine and respirable particles in an automotive grey iron foundry. Ann Occup Hyg. 2008;52:9-21.
70. Heitbrink WA, Evans DE, Peters TM, Slavin TJ. Characterization and mapping of very fine particles in an engine machining and assembly facility. J Occup Environ Hyg. 2007;4:341-351.
71. Mazzuckelli LF, Methner MM, Birch ME, Evans DE, Ku BK, Crouch K. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J Occup Environ Hyg. 2007;4:D125-D 130.
72. Peters TM, Heitbrink WA, Evans DE, Slavin TJ, Maynard AD. The mapping of fine and ultrafine particle concentra-tions in an engine machining and assembly facility. Ann Occup Hyg. 2006;50: 249-257.
73. Nicas M. Using mathematical models to estimate exposure to workplace contaminants. Chem Health Saf. 2003; 10:14-21.
74. Davis ME, Smith TJ, Laden F, Hart JE, Ryan LM, Garshick E. Modeling particle exposure in U.S. trucking terminals. Env Sci Technol. 2006;40:4226-4232.
75. Nanowerk LLC. Nanomaterial Database Search. Available at: http://www.nanowerk.com/phpscripts/n-dbsearch. php. Accessed June 30, 2008.
76. Donaldson K, Aitken R, Tran L, et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci. 2006;92:5-22.
77. Schipper ML, Nakayama-Ratchford N, Davis CR, et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nature Nano- technol. 2008;3:216-221.
78. Roco MC, Bainbridge WS. Societal implications of nanoscience and nanotechnology: maximizing human benefits. J Nanopart Res. 2005;7:1-13.
79. Eurostat. Statistical Classification of Economic Activities in the European Community. Rev 1 (NACE Rev. 1). Eurostat; 1990. Available at: http://www.biggerbooks.com/bk-detail.aspx?isbn=9789282687673.
80. Italian Institute of Statistics. Eighth Consensimento Industria e Servizi [Eighth Census of Industry and Services]. Instituto Nazionale di Statistica [Italian Institute of Statistics]; 2001. Available at: http://dwcis.istat.it/cis/ index.htm.
81. Mangematin V. Emergence of Science Districts and Divergent Technology: The Case of Nanotechiwlogies, Grenoble, France; 2005. Available at: http://www. nanodistrict.org/scientific- output/reports/ Emergence-of-science- districts-and-divergent-technologies.pdf.
82. Porter AL, Youtie J, Shapira P, Schoe- neck DJ. Refining search terms for nanotechnology. J Nanopart Res. 2008; 10:715-728.
83. Roco MC. Nanoscale science and engineering. Unifying and transforming tools. AIChE J. 2004;50:890-897.
84. Youtie J. Mapping the nanotechnology enterprise: a multi-indicator analysis of emerging nanodistricts in the U.S. south. J Technol Transf. 2008;33: 209-223.
85. Freeman R, Kavita S. Jobs in Nano- tech-Creating a Measure of Job Growth. Science and EngineeringWorkforce Project Digest. National Bureau of Economic Research; 2008:1-2.
86. Lundin FE Jr, Lloyd JW, Smith EM, Archer VE, Holaday DA. Mortality of uranium miners in relation to radiation exposure, hard-rock mining and cigarette smoking-1950 through September 1967. Health Phys. 1969; 16:571-578.
87. Schulte PA, Salamanca-Buentello F. Ethical and scientific issues of nanotechnology in the workplace. Environ Health Perspect. 2007;115:5-12.
88. Loft S, Braner EV, Forchammer L, Ped- ersen M, Knudsen LE, Moller P. Complete exposures-air pollution. In: Wild CP, Vineis P, Garte S, eds. Molecular Epidemiology of Chronic Disease. Chicester, UK: John Wiley and Sons Ltd.; 2008:343-538.
89. Makris D, Paraskakis E, Korakas P, et al. Exhaled breath condensate 8-iso- prostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 2008;75:138-144.
90. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-627.
91. Schulte PA. The use of biomarkers in surveillance, medical screening and intervention. Mutat Res. 2005;592:155-163.
92. Birrell MA, McCluskie K, Hardaker E, Knowles R, Belvisi MG. Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model. Eur Respir J. 2006;28: 1236-1244.
93. Driscoll KE. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. In: Mauderly JL, McCunney RJ, eds. Particle Overload in the Rat Lung and Lung Cancer: Implications for Human Risk Assessment. Philadelphia, PA: Taylor & Francis; 1996:139-152.
94. Duffin R, Tran L, Brown D, Stone V, Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol. 2007;19:849- 856.
95. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat Al. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect. 2007;115:403-409.
96. Schulte PA, Kaye WE. Exposure registries. Arch Environ Health. 1988;43: 155-161.
97. Schulte PA, Trout D, Zumwalde RD, et al. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science. J Occup Environ Med. 2008; 50:517-526.
98. Nasterlack M, Zober A, Oberlinner C. Considerations on occupational medical surveillance in employees handling nanoparticles. Int Arch Occup Environ Health. 2008;81:721-726.
99. Kuempel ED, Smith RJ, Dankovic DA, et al. Concordance of rat and human based risk estimates for particle-related lung cancer. Ann Occup Hyg. 2001 ;46: 62-66.
100. Smith TJ. Issues in exposure and dose assessment for epidemiology and risk assessment. Hum Ecol Risk Assess. 2002;8:1267-1293.
101. National Research Council. Health Effects of Exposure to Radon, BEIR VI. Committee on Health Risks of Exposure to Radon (BEIR VI). Washington, DC: National Academy Press; 1999.
102. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation, BEIR VII Phase 2. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Washington, DC: National Academy Press; 2005.
103. Schulte PA, Geraci C, Zumwalde R, Hoover M, Kuempel E. Occupational risk management of engineered nanoparticles. J Occup Environ Hyg. 2007; 5:239-249.